Yüklüyor......
Advances in therapeutic development for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality. The disease originates from low levels of SMN protein due to deletion and/or mutations of SMN1 coupled with the inability of SMN2 to compensate for the loss of SMN1. While SMN1 and SMN2 are nearly identical, SMN2 predomina...
Kaydedildi:
| Yayımlandı: | Future Med Chem |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356243/ https://ncbi.nlm.nih.gov/pubmed/25068989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.14.63 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|